Follitropin beta biosimilar united states?

See the DrugPatentWatch profile for Follitropin

Is there a follitropin beta biosimilar in the US?

Yes. There is at least one follitropin beta biosimilar approved in the United States: Fyremelti (follitropin beta-awwb). It is listed by the FDA and manufactured by Theramex. [1][2]

What brand names and active ingredients are in play?

In the US, the relevant active ingredient is follitropin beta (a follicle-stimulating hormone used for fertility treatment). The biosimilar is marketed as:
- Fyremelti (follitropin beta-awwb) [1][2]

Who makes the approved follitropin beta biosimilar in the US?

Theramex manufactures Fyremelti in the US. [1][2]

How do people usually find the right product in the US?

Patients and clinicians typically look for the specific FDA-approved product name (including the suffix, such as “-awwb”) and confirm it matches their prescribed follitropin beta medicine. The FDA label and prescribing information for Fyremelti are the main references for this. [1][2]

What should a patient or prescriber check before switching?

When switching to a biosimilar, the key practical checks are:
- the exact product name and concentration being dispensed (to match the prescribed regimen), and
- the FDA-approved prescribing information for indications and dosing instructions for the biosimilar. [1][2]

Sources

1. https://www.fda.gov/drugs/biosimilars/fyremelti
   
2. https://labeling.pfizer.com/showlabeling?product=Fyremelti